Your browser doesn't support javascript.
loading
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.
Brokus, Christopher; Kattakuzhy, Sarah; Gayle, Britt; Narayanan, Shivakumar; Davis, Ashley; Cover, Amelia; Eyasu, Rahwa; Ebah, Emade; Ogbumbadiugha-Weekes, Onyinyechi; Hoffmann, Jennifer; Silk, Rachel; Stevens, Jasmine; Mount, Julia; Gannon, Catherine; Nussdorf, Laura; Mathur, Poonam; Bijole, Phyllis; Jones, Miriam; Kier, Randy; Sternberg, David; Greenblatt, Aaron; Weintraub, Eric; Masur, Henry; Kottilil, Shyamasundaran; Rosenthal, Elana.
Afiliación
  • Brokus C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Kattakuzhy S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Gayle B; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Narayanan S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Davis A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Cover A; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Eyasu R; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Ebah E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Ogbumbadiugha-Weekes O; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hoffmann J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Silk R; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Stevens J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Mount J; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Gannon C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Nussdorf L; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Mathur P; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Bijole P; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Jones M; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Kier R; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Sternberg D; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Greenblatt A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Weintraub E; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Masur H; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
  • Kottilil S; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Rosenthal E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.
Open Forum Infect Dis ; 9(3): ofab658, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35187191
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos